4//SEC Filing
Anacor Pharmaceuticals, Inc. 4
Accession 0001209191-15-038191
CIK 0001411158operating
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 7:25 PM ET
Size
6.6 KB
Accession
0001209191-15-038191
Insider Transaction Report
Form 4
Maples Kirk R
Senior VP Program Mgt
Transactions
- Sale
Common Stock
2015-05-01$54.14/sh−500$27,071→ 7,820 total - Sale
Common Stock
2015-05-01$52.99/sh−100$5,299→ 8,320 total
Footnotes (2)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.96 to $54.38, inclusive.
Documents
Issuer
Anacor Pharmaceuticals, Inc.
CIK 0001411158
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001411158
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 7:25 PM ET
- Size
- 6.6 KB